Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 231236, 5 pages
http://dx.doi.org/10.1155/2014/231236
Research Article

The Association of HLA-Class I and Class II with Hodgkin’s Lymphoma in Iranian Patients

1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran
2Department of Medical Genetics, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
3Taleghani Bone Marrow Transplantation Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran
4Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran

Received 4 February 2014; Revised 16 April 2014; Accepted 1 May 2014; Published 21 May 2014

Academic Editor: Isabel Neuringer

Copyright © 2014 Arezou Sayad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Hodgkin, “On some morbid experiences of the absorbent glands and spleen,” Medico-Chirurgical Transactions, vol. 17, pp. 69–97, 1832. View at Google Scholar
  2. S. J. Horning, “Hodgkin lymphoma,” in Williams Hematology, M. A. Lichtman, E. Beutler, and T. J. Kipps, Eds., pp. 1461–1482, McGraw-Hill, New York, NY, USA, 7th edition, 2006. View at Google Scholar
  3. S. Depil, O. Moralès, and C. Auriault, “Hodgkin's disease and Epstein-Barr virus,” Annales de Biologie Clinique, vol. 62, no. 6, pp. 639–648, 2004. View at Google Scholar · View at Scopus
  4. J. H. Brown, T. S. Jardetzky, J. C. Gorga et al., “Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1,” Nature, vol. 364, no. 6432, pp. 33–39, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. R. N. Germain, “MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation,” Cell, vol. 76, no. 2, pp. 287–299, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hammer, “New methods to predict MHC-binding sequences within protein antigens,” Current Opinion in Immunology, vol. 7, no. 2, pp. 263–269, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Hammer, F. Gallazzi, E. Bono et al., “Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1847–1855, 1995. View at Google Scholar · View at Scopus
  8. J. Amiel, “Study of the leukocyte phenotypes in Hodgkin’s disease,” in Histocompatibility Testing, P. I. Teraski, Ed., pp. 79–81, Munksgaard, Copenhagen, Denmark, 1967. View at Google Scholar
  9. A. Chakravarti, S. L. Halloran, S. J. Bale, and M. A. Tucker, “Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance,” Genetic Epidemiology, vol. 3, no. 6, pp. 407–415, 1986. View at Google Scholar · View at Scopus
  10. J. Hors, G. Steinberg, J. M. Andrieu et al., “HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected sibs,” European Journal of Cancer and Clinical Oncology, vol. 16, no. 6, pp. 809–815, 1980. View at Google Scholar · View at Scopus
  11. W. Klitz, C. L. Aldrich, N. Fildes, S. J. Horning, and A. B. Begovich, “Localization of predisposition to Hodgkin disease in the HLA class II region,” American Journal of Human Genetics, vol. 54, no. 3, pp. 497–505, 1994. View at Google Scholar · View at Scopus
  12. A. M. Oza, S. Tonks, J. Lim, M. A. Fleetwood, T. A. Lister, and J. G. Bodmer, “A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease,” Cancer Research, vol. 54, no. 19, pp. 5101–5105, 1994. View at Google Scholar · View at Scopus
  13. S. Tonks, A. M. Oza, T. A. Lister, and J. G. Bodmer, “Association of HLA-DPB with Hodgkin's disease,” The Lancet, vol. 340, no. 8825, pp. 968–969, 1992. View at Google Scholar · View at Scopus
  14. W. H. Marshall, J. M. Barnard, S. K. Buehler, J. Crumley, and B. Larsen, “HLA in familial Hodgkin's disease. Results and a new hypothesis,” International Journal of Cancer, vol. 19, no. 4, pp. 450–455, 1977. View at Google Scholar · View at Scopus
  15. M. Niens, A. van den Berg, A. Diepstra et al., “The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2280–2284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Niens, R. F. Jarrett, B. Hepkema et al., “HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma,” Blood, vol. 110, no. 9, pp. 3310–3315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Sayad, A. Allameh, A. Sayad et al., “The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients,” Cell Journal, vol. 15, no. 2, pp. 124–129, 2013. View at Google Scholar
  18. A. Sayad, A. Allameh, A. Sayad, M. Norouzinia, and A. Sarzaeem, “The influence of -330 IL-2 gene polymorphism on relapsing remitting and secondary progressive course multiple sclerosis in Iranian patients,” Neurology Asia, vol. 18, no. 1, pp. 83–86, 2013. View at Google Scholar
  19. A. Sayad, M. T. Akbari, M. Pajouhi, F. Mostafavi, A. Kazemnejad, and M. Zamani, “The role of the gender on the HLA-DRB1 and DQB1 association with type 1 diabetes mellitus in Iranian patients,” Cell Journal, vol. 15, no. 2, pp. 108–115, 2013. View at Google Scholar
  20. A. Sayad, M. T. Akbari, M. Pajouhi, F. Mostafavi, and M. Zamani, “The influence of the HLA-DRB, DQB and polymorphic positions of the HLA-DRβ1 and HLA-DQβ1 molecules on risk of Iranian type 1 diabetes mellitus patients,” International Journal of Immunogenetics, vol. 39, pp. 429–436, 2012. View at Google Scholar
  21. A. Hajifathali, A. Sayad, A. Sayad et al., “The association of -308 TNFα polymorphism and multiple sclerosis in Iranian patients,” Journal of Biology and Today's World, vol. 1, no. 2, pp. 114–121, 2012. View at Google Scholar
  22. A. M. Ferraris, O. Racchi, D. Rapezzi, G. F. Gaetani, and P. Boffetta, “Familial Hodgkin’s disease: a disease of young adulthood?” Annals of Hematology, vol. 74, pp. 131–134, 1997. View at Google Scholar
  23. L. Moutsianas, V. Enciso-Mora, Y. P. Ma et al., “Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3,” Blood, vol. 118, no. 3, pp. 670–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Svejgaard, P. Platz, and L. P. Ryder, “HL A and disease associations. A survey,” Transplantation Reviews, vol. 22, pp. 3–43, 1975. View at Google Scholar · View at Scopus
  25. M. Bjorkholm, G. Holm, B. Johansson, H. Mellstedt, and E. Moller, “A prospective study of HL A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease,” Tissue Antigens, vol. 6, no. 4, pp. 247–256, 1975. View at Google Scholar · View at Scopus
  26. G. M. Taylor, D. A. Gokhale, and D. Crowther, “Increased frequency of HLA-DPB1*0301 in Hodgkin’s disease suggests that susceptibility is HVR-sequence and subtype-associated,” Leukemia, vol. 10, pp. 854–859, 1996. View at Google Scholar
  27. Y. Al-Tonbary, N. Abdel-Razek, H. Zaghloul, S. Metwaly, B. El-Deek, and R. El-Shawaf, “HLA class II polymorphism in Egyptian children with lymphomas,” Hematology, vol. 9, no. 2, pp. 139–145, 2004. View at Google Scholar · View at Scopus
  28. L. C. Harty, A. Y. Lin, A. M. Goldstein et al., “HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease,” Blood, vol. 99, no. 2, pp. 690–693, 2002. View at Publisher · View at Google Scholar · View at Scopus